Bis(7)-harmine derivatives as potential multi-target anti-Alzheimer agents

IntroductionThe multi-targeted ligands (MTDL) strategy has been recognized as a promising Approach for the development of effective treatments against Alzheimer’s disease (AD), due to the presence of multiple pathological mechanisms in AD. In this study, a series of bis(7)-harmine derivatives were d...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongtao Du, Fang Ma, Yuanyuan Cao, Miaoyan Bai, Xinyi Gao, Ziyi Yang, Yang Xu, Yan Yan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Chemistry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fchem.2025.1545908/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832582936152506368
author Hongtao Du
Hongtao Du
Hongtao Du
Fang Ma
Fang Ma
Yuanyuan Cao
Miaoyan Bai
Xinyi Gao
Ziyi Yang
Yang Xu
Yan Yan
Yan Yan
author_facet Hongtao Du
Hongtao Du
Hongtao Du
Fang Ma
Fang Ma
Yuanyuan Cao
Miaoyan Bai
Xinyi Gao
Ziyi Yang
Yang Xu
Yan Yan
Yan Yan
author_sort Hongtao Du
collection DOAJ
description IntroductionThe multi-targeted ligands (MTDL) strategy has been recognized as a promising Approach for the development of effective treatments against Alzheimer’s disease (AD), due to the presence of multiple pathological mechanisms in AD. In this study, a series of bis(7)-harmine derivatives were designed and synthesized as multifunctional drugs for the treatment of AD.MethodsThe derivatives were synthesized by chemical methods and their structure was confirmed by nuclear magnetic resonance (NMR). The Ellman’s assay was utilized to assess the inhibitory potential of derivatives against hAChE and hBuChE. The inhibitory activity of these derivatives on both hMAO-A and hMAO-B was assessed using a fluorescence-based method. The thioflavin T (Th-T) fluorescence assay was used to assess the inhibition of Aβ1−42 self-aggregation. The cytotoxicity was evaluated using the MTT assay. The Surflex-Dock program in Sybyl-X2.0 Software was employed for molecular docking.ResultsIn vitro studies revealed that numerous synthesized compounds exhibited potent inhibitory activity against hAChE, and hMAO-B (IC50 < 1 μM), as well as Aβ1−42 aggregation (IC50 < 20 μM). Importantly, the multitarget compounds 6d, 8c, and 8d exhibited remarkable efficacy in simultaneously mitigating Aβ-induced toxicity in SH−SY5Y cells while demonstrating minimal cytotoxicity. Furthermore, predicted ADMET results suggested that 6d, 8c, and 8d possessed favorable pharmacokinetic properties and demonstrated low toxicity levels. Additionally, molecular docking studies of 6d within the activesites of hAChE, hMAO-B, and Aβ1−42 elucidated the inhibition mechanism.Discussion and conclusionBased on these findings, it is evident that 6d, 8c, and 8d hold potential as promising multi-functional drugs for AD treatment.
format Article
id doaj-art-340fb71f10af49c3b22c768faf99b95d
institution Kabale University
issn 2296-2646
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Chemistry
spelling doaj-art-340fb71f10af49c3b22c768faf99b95d2025-01-29T06:45:41ZengFrontiers Media S.A.Frontiers in Chemistry2296-26462025-01-011310.3389/fchem.2025.15459081545908Bis(7)-harmine derivatives as potential multi-target anti-Alzheimer agentsHongtao Du0Hongtao Du1Hongtao Du2Fang Ma3Fang Ma4Yuanyuan Cao5Miaoyan Bai6Xinyi Gao7Ziyi Yang8Yang Xu9Yan Yan10Yan Yan11Shaanxi Key Laboratory of Chinese Jujube, College of Life Sciences, Yan’an University, Yan’an, Shaanxi, ChinaShaanxi Qi Yuan Kang Bo Biotechnology Co., Ltd., Tongchuan, Shaanxi, ChinaCollege of Life Science, Xinyang Normal University, Xinyang, ChinaShaanxi Key Laboratory of Chinese Jujube, College of Life Sciences, Yan’an University, Yan’an, Shaanxi, ChinaShaanxi Qi Yuan Kang Bo Biotechnology Co., Ltd., Tongchuan, Shaanxi, ChinaShaanxi Key Laboratory of Chinese Jujube, College of Life Sciences, Yan’an University, Yan’an, Shaanxi, ChinaShaanxi Key Laboratory of Chinese Jujube, College of Life Sciences, Yan’an University, Yan’an, Shaanxi, ChinaShaanxi Key Laboratory of Chinese Jujube, College of Life Sciences, Yan’an University, Yan’an, Shaanxi, ChinaShaanxi Key Laboratory of Chinese Jujube, College of Life Sciences, Yan’an University, Yan’an, Shaanxi, ChinaShaanxi Key Laboratory of Chinese Jujube, College of Life Sciences, Yan’an University, Yan’an, Shaanxi, ChinaShaanxi Key Laboratory of Chinese Jujube, College of Life Sciences, Yan’an University, Yan’an, Shaanxi, ChinaNorthwest A&F University, Xianyang, Shaanxi, ChinaIntroductionThe multi-targeted ligands (MTDL) strategy has been recognized as a promising Approach for the development of effective treatments against Alzheimer’s disease (AD), due to the presence of multiple pathological mechanisms in AD. In this study, a series of bis(7)-harmine derivatives were designed and synthesized as multifunctional drugs for the treatment of AD.MethodsThe derivatives were synthesized by chemical methods and their structure was confirmed by nuclear magnetic resonance (NMR). The Ellman’s assay was utilized to assess the inhibitory potential of derivatives against hAChE and hBuChE. The inhibitory activity of these derivatives on both hMAO-A and hMAO-B was assessed using a fluorescence-based method. The thioflavin T (Th-T) fluorescence assay was used to assess the inhibition of Aβ1−42 self-aggregation. The cytotoxicity was evaluated using the MTT assay. The Surflex-Dock program in Sybyl-X2.0 Software was employed for molecular docking.ResultsIn vitro studies revealed that numerous synthesized compounds exhibited potent inhibitory activity against hAChE, and hMAO-B (IC50 < 1 μM), as well as Aβ1−42 aggregation (IC50 < 20 μM). Importantly, the multitarget compounds 6d, 8c, and 8d exhibited remarkable efficacy in simultaneously mitigating Aβ-induced toxicity in SH−SY5Y cells while demonstrating minimal cytotoxicity. Furthermore, predicted ADMET results suggested that 6d, 8c, and 8d possessed favorable pharmacokinetic properties and demonstrated low toxicity levels. Additionally, molecular docking studies of 6d within the activesites of hAChE, hMAO-B, and Aβ1−42 elucidated the inhibition mechanism.Discussion and conclusionBased on these findings, it is evident that 6d, 8c, and 8d hold potential as promising multi-functional drugs for AD treatment.https://www.frontiersin.org/articles/10.3389/fchem.2025.1545908/fullAlzheimer’s diseaseharmineacetylcholinesterasemonoamine oxidaseamyloid peptide (Aβ)
spellingShingle Hongtao Du
Hongtao Du
Hongtao Du
Fang Ma
Fang Ma
Yuanyuan Cao
Miaoyan Bai
Xinyi Gao
Ziyi Yang
Yang Xu
Yan Yan
Yan Yan
Bis(7)-harmine derivatives as potential multi-target anti-Alzheimer agents
Frontiers in Chemistry
Alzheimer’s disease
harmine
acetylcholinesterase
monoamine oxidase
amyloid peptide (Aβ)
title Bis(7)-harmine derivatives as potential multi-target anti-Alzheimer agents
title_full Bis(7)-harmine derivatives as potential multi-target anti-Alzheimer agents
title_fullStr Bis(7)-harmine derivatives as potential multi-target anti-Alzheimer agents
title_full_unstemmed Bis(7)-harmine derivatives as potential multi-target anti-Alzheimer agents
title_short Bis(7)-harmine derivatives as potential multi-target anti-Alzheimer agents
title_sort bis 7 harmine derivatives as potential multi target anti alzheimer agents
topic Alzheimer’s disease
harmine
acetylcholinesterase
monoamine oxidase
amyloid peptide (Aβ)
url https://www.frontiersin.org/articles/10.3389/fchem.2025.1545908/full
work_keys_str_mv AT hongtaodu bis7harminederivativesaspotentialmultitargetantialzheimeragents
AT hongtaodu bis7harminederivativesaspotentialmultitargetantialzheimeragents
AT hongtaodu bis7harminederivativesaspotentialmultitargetantialzheimeragents
AT fangma bis7harminederivativesaspotentialmultitargetantialzheimeragents
AT fangma bis7harminederivativesaspotentialmultitargetantialzheimeragents
AT yuanyuancao bis7harminederivativesaspotentialmultitargetantialzheimeragents
AT miaoyanbai bis7harminederivativesaspotentialmultitargetantialzheimeragents
AT xinyigao bis7harminederivativesaspotentialmultitargetantialzheimeragents
AT ziyiyang bis7harminederivativesaspotentialmultitargetantialzheimeragents
AT yangxu bis7harminederivativesaspotentialmultitargetantialzheimeragents
AT yanyan bis7harminederivativesaspotentialmultitargetantialzheimeragents
AT yanyan bis7harminederivativesaspotentialmultitargetantialzheimeragents